β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutationFelipe C. Geyer, Jorge S. Reis‐Filho, Magali Lacroix‐Triki et al.|Modern Pathology|2010Cited by 377
<i>FGFR1</i> Emerges as a Potential Therapeutic Target for Lobular Breast CarcinomasJorge S. Reis‐Filho, Alan Ashworth, Peter T. Simpson et al.|Clinical Cancer Research|2006Cited by 272
<i>EGFR</i> amplification and lack of activating mutations in metaplastic breast carcinomasJS Reis‐Filho, Schmitt Fc, Sunil R. Lakhani et al.|The Journal of Pathology|2006Cited by 268
PTEN Deficiency in Endometrioid Endometrial Adenocarcinomas Predicts Sensitivity to PARP InhibitorsKonstantin J. Dedes, Jorge S. Reis‐Filho, Daniel Wetterskog et al.|Science Translational Medicine|2010Cited by 257
Molecular analysis reveals a genetic basis for the phenotypic diversity of metaplastic breast carcinomasFelipe C. Geyer, Jorge S. Reis‐Filho, Britta Weigelt et al.|The Journal of Pathology|2009Cited by 255